GlassScriptPhysician profile
Maria Isabel Colome
NPI 1033214689
$795.77
in general payments reported to CMS, 2019-2025
12 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Dermatopathology (Dermatology) provider received nationally (typical 2025 total: $251).
See the full distribution for Dermatopathology (Dermatology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.90 · 2022: $58.15 · 2023: $287 · 2024: $173 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $153.80 | 2023 | |
| Ucb, INC. | $152.86 | 2021-2024 | Cimzia, Bimzelx |
| Arcutis Biotherapeutics, INC. | $137.26 | 2025 | Zoryve |
| Lilly USA, LLC | $73.33 | 2023-2024 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $72.44 | 2023-2025 | Simponi, Stelara, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $50.48 | 2022-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $41.46 | 2024 | |
| Incyte Corporation | $37.81 | 2021-2022 | |
| Amgen INC. | $22.85 | 2025 | Otezla |
| Genzyme Corporation | $21.69 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.28 | 2025 | Jublia, Siliq, Cabtreo |
| Abbvie INC. | $14.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Colome listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.